Franceschi, E., Finocchiaro, G., Zagonel, V., Reni, M., Fabi, A., Caserta, C., Clavarezza, M., Maiello, E., Cartený, G., Rosti, G., Tosoni, A., Paccapelo, A., Proietti, E., Agati, R., & Brandes, A. (n.d.). 2924 Time to response (TTR) and early tumor shrinkage (ETS) in recurrent glioblastoma patients treated with bevacizumab: An exploratory analysis of the prospective randomized AVAREG (ML25739) phase II study. European journal of cancer, 51, S592–. http://access.bl.uk/ark:/81055/vdc_100030628298.0x000053